株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の分子細胞遺伝学市場

Molecular Cytogenetics

発行 Global Industry Analysts, Inc. 商品コード 210366
出版日 ページ情報 英文 194 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.43円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
世界の分子細胞遺伝学市場 Molecular Cytogenetics
出版日: 2019年05月01日 ページ情報: 英文 194 Pages
概要

当レポートでは、世界の分子細胞遺伝学市場について調査し、市場の動向とセグメント別概要、地域別動向、および市場に参入主要企業のプロファイルと競合動向についてまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 業界概要

  • 分子細胞遺伝学技術:イントロダクション
  • 細胞遺伝学技術に有望な将来的見通し
  • ライフサイエンスの研究開発と医療支出が好ましい環境を作り出す
  • 先進国:主な収益貢献国
  • 途上国の急速な成長見通し
  • 経済的シナリオが促進する市場の拡大

第3章 市場動向、促進因子

  • ラボラトリプロセスにおける分子生物学の重要性
  • 分子生物学技術の進歩
  • アレイベース技術:最大かつ最速で成長する市場セグメント
  • FISHからアレイ技術への移行
  • 次世代シーケンシングが細胞遺伝学プロセスにおける役割を模索
  • 癌の予後にも大きく寄与
  • FISH技術の多様な応用 他

第4章 技術概要

  • 細胞遺伝学の序論
  • 分子生物学の基本的用語と定義
  • 分子細胞遺伝学:定義と範囲
  • 分子細胞遺伝学の応用
  • 技術動向
  • マイクロアレイ技術の探求 他

第5章 競合環境

  • 主要企業
  • 製品上市
  • 近年の業界活動

第6章 世界市場見通し

第7章 地域別市場見通し

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ

第8章 企業プロファイル

目次
Product Code: MCP-6759

This report analyzes the worldwide markets for Molecular Cytogenetics in US$ Thousand by the following Technologies: Fluorescence In Situ Hybridization, and Array-based Technology. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 27 companies including many key and niche players such as -

Abbott Molecular, Inc.
Agilent Technologies, Inc.
Applied Spectral Imaging
Biological Industries
Bio-Rad Laboratories, Inc.
Cytognomix, Inc.

Table of Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
  • Definitions
    • Fluorescence In Situ Hybridization (FISH)
      • Select FISH Procedures in Use
      • 3D-FISH
      • Cellular Compartment Analysis of Temporal Activity
      • Combined Binary Ratio-FISH
      • Cryo-FISH
      • Immuno-FISH
      • Quantum Dot-Conjugates-FISH
    • Array-based Technology
      • Array-based Comparative Genomic Hybridization (aCGH)

2. INDUSTRY OVERVIEW

  • Molecular Cytogenetics Technologies: An Introductory Prelude
  • Future Prospects Remain Favorable for Cytogenetics Technologies
  • Uptrend in Life Sciences R&D and Healthcare Spending Creates Fertile Environment
    • Table 1: Global Pharmaceutical R&D Spending (in US$ Billion) for the Years 2010 through 2017 (includes corresponding Graph/Chart)
    • Table 2: Leading Countries with Highest Healthcare Spending as a Percentage (%) of GDP (2016) (includes corresponding Graph/Chart)
    • Table 3: Per Capita Healthcare Spending (in US$) in Select Countries (2016) (includes corresponding Graph/Chart)
  • Northbound Trajectory in Med Tech Sector Generates Parallel Opportunities
  • Developed Regions: Key Revenue Contributors
    • Table 4: Developed Regions Account for Lion's Share of World Molecular Cytogenetics Technologies Market: Percentage Breakdown of Revenues for Developed and Developing Regions (2018E & 2022P) (includes corresponding Graph/Chart)
  • Fast Paced Growth Projected in Developing Regions
    • Table 5: Global Market for Molecular Cytogenetics Technologies - Geographic Regions Ranked by % CAGR (Revenues) for 2015-2022: Asia-Pacific, Rest of World, Canada, US, Europe, and Japan (includes corresponding Graph/Chart)
  • Prevailing Economic Scenario Favors Market Expansion
    • Table 6: World Real GDP Growth Rates in % (2016-2019P): Breakdown by Country/Region (includes corresponding Graph/Chart)

3. KEY MARKET TRENDS & GROWTH DRIVERS

  • Critical Importance of Molecular Biology in Laboratory Processes: Cornerstone for Present & Future Growth
  • Advanced Molecular Biology Techniques Broaden the Scope of Cytogenetics Technologies
  • Array-based Technologies: Largest & Fastest Growing Market Segment
  • Transition from FISH to Array Based Technologies: The Ongoing Trend
    • Table 7: Array-based Technologies Continue to Cannibalize Sales from FISH Technology: Percentage (%) Share of Array-Based Solutions in World Cytogenetics Technologies Market (2018E & 2022P) (includes corresponding Graph/Chart)
  • Array-based CGH to Emerge as First Line Test for Clinical Diagnosis of Chromosomal Anomalies
  • Molecular Cytogenetics Find Increasing Penetration in Clinical Pathological Testing
  • Enhanced AP LIS: A Must to Keep Pace with Advancing Molecular Cytogenetic Testing
  • Impact of Shifting Focus of Biopharmaceuticals from Research to Development on Microarray Technology
  • Despite Proliferation of Array-based Methods, FISH Technology Continues to Find Favor
  • Next-Gen Sequencing Seeks Role in Cytogenetics Processes
  • Molecular Cytogenetics Greatly Benefit Cancer Prognosis
  • Diverse Applications of FISH Technology in Oncology
  • Opportunity Indicator: Global Cancer Incidence on the Rise
    • Table 8: Global Cancer Incidence (2015): Number of New Cancer Cases in Thousands by Type and Gender (includes corresponding Graph/Chart)
    • Table 9: Global Cancer Mortality (2015): Number of Cancer Related Deaths in Thousands by Type and Gender (includes corresponding Graph/Chart)
    • Table 10: Worldwide Incidence of Cancer in Millions: 2012, 2020P & 2030P (includes corresponding Graph/Chart)
  • Increasing Significance of Cytogenetic Analysis in Genetic Disease Diagnosis
  • Proven Efficacy in Nucleic Acid Diagnostics Favors Market Growth
  • Expanding Role of Molecular Cytogenetics in Personalized Medicine
    • Table 11: World Market for Personalized Medicine: Breakdown of Annual Revenues (in US$ Billion) for 2014, 2018E and 2022P (includes corresponding Graph/Chart)
    • Table 12: World Personalized Medicine Market by Region/Country (2018E): Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific and Rest of World (includes corresponding Graph/Chart)
    • Table 13: Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population (includes corresponding Graph/Chart)
  • Demographics Spell Growth Opportunities
    • Table 14: Percentage Breakdown of Global Population by Age Group: 2015, 2050, and 2100 (includes corresponding Graph/Chart)
    • Table 15: 60+ Years Individuals as a Percentage of Total Population in Major Countries Worldwide: 2015, 2050, and 2100 (includes corresponding Graph/Chart)

4. TECHNOLOGY OVERVIEW

  • A Preface to Cytogenetics
  • Basic Terms and Definitions in Molecular Biology
  • DNA and RNA
  • RNA (Ribose nucleic acid)
  • Chromosomes
  • Gene
  • Genotype
  • Phenotype
  • Haplotype
  • Karyotyping
  • Karyotype
  • Nick
  • Probe
  • Reporter Molecule
  • Copy Number
  • Copy Number Variation
  • Analysis of Copy Numbers Variations
  • Chromosomal Abnormalities in Human Beings
  • An Overview of Select Chromosomal Anomalies
  • Insertions
  • Deletions
  • Duplication
  • Rearrangement
  • Select Human Diseases/Abnormalities Arising due to Translocations
  • Molecular Cytogenetics: Definition and Scope
  • Application of Molecular Cytogenetics
  • Insight into Molecular Cytogenetics Techniques
  • Fluorescence in situ Hybridization (FISH)
    • What is In Situ Hybridization?
    • How is FISH Better than Conventional Techniques?
    • Fluorescence In Situ Hybridization: The Process
    • Probe Types and Application
      • Types of Probes
      • Common Methods of Probe Preparation
      • Nick Translation and Polymerase Chain Reaction (PCR)
  • Applications of FISH
  • Types of FISH
  • 3D-FISH
  • ACM-FISH or Multicolor FISH
  • ArmFISH
  • Catalyzed Reporter Deposition-FISH
  • Cellular Compartment Analysis of Temporal Activity
  • Cytochalasin-B -FISH
  • Combined Binary Ratio-FISH
  • Chromosome Orientation And Direction FISH
  • Combinatorial Oligonucleotide-FISH
  • Comet-FISH
  • Cryo-FISH
  • Double-Fusion-FISH
  • DNA Breakage Detection -FISH
  • e-FISH
  • Fiber-FISH
  • Flow-FISH
  • Fusion-Signal FISH
  • Halo-FISH
  • Harlequin-FISH
  • Immuno-FISH
  • Locked Nucleic Acids-FISH
  • M-FISH
  • Multilocus-FISH
  • Premature Chromosome Condensation-FISH
  • Peptide Nucleic Acids-FISH
  • Novel FISH Technology to Detect Plague Bacillus
  • Quantitative-FISH
  • Quantum Dot-Conjugates-FISH
  • Rainbow-FISH
  • Reverse-FISH
  • Recognition of Individual Genes-FISH
  • Expression-FISH
  • RxFISH
  • Split-Signal FISH
  • Telomere-FISH/ Tissue-FISH/ Tyramide-FISH (T-FISH)
  • Zoo-FISH
  • Spectral Karyotyping (SKY) Technique
  • Mouse FISH - a New Development
  • Comparative Genomic Hybridization (CGH)
  • CGH: The Process
  • CGH: Applications In Clinical Cytogenetics
  • Benefits of CGH Analysis in Clinical Genetics
  • Limitations of CGH
  • Advent of Microarray Technology
  • What are Microarrays?
  • Microarrays in Gene Expression Analysis
  • Microarrays in Comparative Genomic Hybridization
  • Principle Underlying aCGH
  • Low Resolution and High Resolution aCGH
  • ACGH: The Process
  • aCGH: Potential Uses and Limitations
    • Potential Advantages of aCGH could be summarized as below
  • Limitations of aCGH
    • Analytical and Post-analytical Limitations
  • Interpretation of Results
  • Applications of aCGH
    • A Review of Molecular Biology Techniques in Cytogenetics

5. COMPETITIVE LANDSCAPE

  • American Companies Dominate the Cytogenetics Technologies Market
  • Competition from European Vendors Remains Firm
  • Vendors Emphasize Collaborations
  • Select Cytogenetics Technology Collaborations Announced in the Recent Past
  • M&A Activity
  • Select Recently Finalized M&A Deals in the Cytogenetics Technologies Marketplace
  • 5.1 Focus on Select Global Players
  • Abbott Molecular (USA)
  • Agilent Technologies, Inc. (USA)
  • Applied Spectral Imaging (USA)
  • Biological Industries (Israel)
  • Bio-Rad Laboratories, Inc. (USA)
  • Cytognomix, Inc. (Canada)
  • CytoTest, Inc. (USA)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Illumina, Inc. (USA)
  • Leica Biosystems Nussloch GmbH (Germany)
  • Oxford Gene Technology (UK)
  • PerkinElmer, Inc. (USA)
  • SciGene Corporation (USA)
  • Thermo Fisher Scientific, Inc. (USA)
  • 5.2 Product Launches
  • SciGene Introduces CytoBrite(r) PLUS Slide Incubation System
  • ASI Unveils Updated GenASIs Platform
  • 5.3 Recent Industry Activity
  • OGT Leverages Sysmex's European Network to Sell Cytocell FISH Products
  • Roche Molecular Systems to Shut NimbleGen Facility
  • Sysmex to Acquire Oxford Gene Technology
  • GeneDx Joins Hands with UC Health for Molecular Testing Services
  • Empire Genomics Teams Up with KromaTiD for Oncology Diagnostics
  • CytoTest Expands Sales Team in Europe
  • Thermo Fisher Scientific Acquires Affymetrix
  • Agilent Inks Co-Marketing Agreement with Applied Spectral Imaging
  • Empire Genomics Expands Global Distribution Network
  • CytoTest and CapitalBio to Jointly Develop Advanced Molecular Diagnostic Solutions

6. GLOBAL MARKET PERSPECTIVE

    • Table 16: World Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 17: World Historic Review for Molecular Cytogenetics Technologies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 18: World 14-Year Perspective for Molecular Cytogenetics Technologies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • By Technology
    • Table 19: World Recent Past Current & Future Analysis for Fluorescence In Situ Hybridization (FISH) Technology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 20: World Historic Review for Fluorescence In Situ Hybridization (FISH) Technology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 21: World 14-Year Perspective for Fluorescence In Situ Hybridization (FISH) Technology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
    • Table 22: World Recent Past Current & Future Analysis for Array-Based Technology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 23: World Historic Review for Array-Based Technology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 24: World 14-Year Perspective for Array-Based Technology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

7. REGIONAL MARKET PERSPECTIVE

  • 7.1 The United States
  • A. Market Analysis
    • The United States: Prime Market for Cytogenetics Technologies
    • Table 25: US Accounts for over 2/5th Share of World Cytogenetics Technologies Market: Percentage Breakdown of Revenues for US and Rest of World (2018E & 2022P) (includes corresponding Graph/Chart)
    • aCGH Predominate the Technological Front in Molecular Cytogenetics
      • The Clinical Sector: A Potential Market Opportunity for Array-based Technologies
      • Revised ACMG Guidelines to Accelerate Use of aCGH Over FISH Technology
    • Established Role of FISH Technology in Cytogenetics Applications
      • FISH in Diagnosis of Bladder Carcinoma
      • FISH in Breast Cancer Diagnosis
      • Restraints for Oncology FISH Probes
      • IHC Tests Curtail FISH Demand
    • Ageing Population and Growing Incidence of Cancer & Lifestyle Diseases - Opportunity Indicators
    • Table 26: US Elderly Population by Age Group for Years 1990, 2000, 2010 and 2015 (includes corresponding Graph/Chart)
    • Table 27: Cancer Incidence in the US by Gender (2018E): Estimated New Cases for Men and Women (includes corresponding Graph/Chart)
    • Table 28: Cancer Incidence in the US by Gender (2018E): Estimated Deaths for Men and Women (includes corresponding Graph/Chart)
    • Emphasis on Personalized Medicine & Companion Diagnostics Widens Scope
    • Table 29: US Personalized Medicine Market: Breakdown of Revenues (in US$ Billion) for 2014, 2018E and 2022P (includes corresponding Graph/Chart)
    • Table 30: US Companion Diagnostics (CDx) Market: Breakdown of Revenues (in US$ Million) for 2014, 2018E and 2022P (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 31: The US Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 32: The US Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 33: The US 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.2 Canada
  • Market Analysis
    • Table 34: Canadian Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 35: Canadian Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 36: Canadian 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.3 Japan
  • A. Market Analysis
    • Japan Offers Robust Opportunities
    • Demographics Favor Demand Expansion
    • Table 37: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)
    • Table 38: Japanese Population by Age Group (2017): Percentage Breakdown for 0-14 Years, 15-24 Years, 25-54 Years, 55-64 Years, 65 Years and Above (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 39: Japanese Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 40: Japanese Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 41: Japanese 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.4 Europe
  • A. Market Analysis
    • A Mature yet Growing Market
      • Analysis by Region
      • Analysis by Technology
    • Cancer Statistics in Europe
    • Table 42: Number of New Cancer Cases in Europe: 2012-2030 (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 43: European Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 44: European Historic Review for Molecular Cytogenetics Technologies by Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 45: European 14-Year Perspective for Molecular Cytogenetics Technologies by Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2018 & 2022 (includes correspondingGraph/Chart)
    • Table 46: European Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 47: European Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 48: European 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.4.1 France
  • Market Analysis
    • Table 49: French Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 50: French Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 51: French 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.4.2 Germany
  • Market Analysis
    • Table 52: German Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 53: German Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 54: German 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.4.3 Italy
  • Market Analysis
    • Table 55: Italian Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 56: Italian Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 57: Italian 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.4.4 The United Kingdom
  • Market Analysis
    • Table 58: The UK Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 59: The UK Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 60: The UK 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.4.5 Spain
  • Market Analysis
    • Table 61: Spanish Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 62: Spanish Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 63: Spanish 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.4.6 Russia
  • Market Analysis
    • Table 64: Russian Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 65: Russian Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 66: Russian 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.4.7 Rest of Europe
  • Market Analysis
    • Table 67: Rest of Europe Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 68: Rest of Europe Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 69: Rest of Europe 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.5 Asia-Pacific
  • A. Market Analysis
    • Asia-Pacific Evolves as Fastest Growing Market
      • Analysis by Region
      • Analysis by Technology
    • Factors Driving Demand for Laboratory Technologies in Asia-Pacific: A Review
      • Growing Biotech Sector
      • Increased Access to Healthcare & Rising Healthcare Awareness
      • Proliferation of Medical Tourism
  • B. Market Analytics
    • Table 70: Asia-Pacific Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 71: Asia-Pacific Historic Review for Molecular Cytogenetics Technologies by Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 72: Asia-Pacific 14-Year Perspective for Molecular Cytogenetics Technologies by Region - Percentage Breakdown of Dollar Sales for China, and Rest of Asia-Pacific Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
    • Table 73: Asia-Pacific Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 74: Asia-Pacific Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 75: Asia-Pacific 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.5.1 China
  • A. Market Analysis
    • China - A Market Laden with Opportunities
    • FISH Technology in Clinical Diagnostics
  • B. Market Analytics
    • Table 76: Chinese Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 77: Chinese Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 78: Chinese 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.5.2 Rest of Asia-Pacific
  • A. Market Analysis
    • An Insight into the Indian Microarray Market
  • B. Market Analytics
    • Table 79: Rest of Asia-Pacific Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 80: Rest of Asia-Pacific Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 81: Rest of Asia-Pacific 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)
  • 7.6 Rest of World
  • Market Analysis
    • Table 82: Rest of World Recent Past Current & Future Analysis for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 83: Rest of World Historic Review for Molecular Cytogenetics Technologies by Technology Type - FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 84: Rest of World 14-Year Perspective for Molecular Cytogenetics Technologies by Technology Type - Percentage Breakdown of Dollar Sales for FISH (Fluorescence in Situ Hybridization) and Array-based Technology Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

8. COMPANY PROFILES

  • Total Companies Profiled: 27 (including Divisions/Subsidiaries - 29) The United States (20) Canada (1) Europe (6) - Germany (2) - The United Kingdom (1) - Rest of Europe (3) Asia-Pacific (Excluding Japan) (1)
Back to Top